Page last updated: 2024-09-04

vatalanib and Adenocarcinoma, Follicular

vatalanib has been researched along with Adenocarcinoma, Follicular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Eilles, C; Grimm, D; Infanger, M; Kossmehl, P; Kurth, E; Schoenberger, J	1

Other Studies

1 other study(ies) available for vatalanib and Adenocarcinoma, Follicular

Article	Year
Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal study. Endocrinology, 2004, Volume: 145, Issue:3 Topics: Adenocarcinoma, Follicular; Angiogenesis Inhibitors; Animals; Cell Differentiation; Cell Line, Tumor; Extracellular Matrix Proteins; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Thyroglobulin; Thyroid Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2004

Article

Year

Effects of PTK787/ZK222584, a tyrosine kinase inhibitor, on the growth of a poorly differentiated thyroid carcinoma: an animal study.

Endocrinology, 2004, Volume: 145, Issue:3

Topics: Adenocarcinoma, Follicular; Angiogenesis Inhibitors; Animals; Cell Differentiation; Cell Line, Tumor; Extracellular Matrix Proteins; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Phthalazines; Protein-Tyrosine Kinases; Pyridines; Thyroglobulin; Thyroid Neoplasms; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2004